US criticizes Zambia over stalled $1 billion health aid deal

Patients in Zambia face the sharpest risk from the breakdown of a $1 billion U.S. health aid agreement: fewer guarantees for HIV treatment, malaria control, maternal care and epidemic readiness if the money stays tied up in a stalled deal. The deadline passed on April 30 without a signed memorandum of understanding, leaving one of southern Africa’s most important public-health partnerships without a formal framework.

The United States has criticized Zambia for what it described as a failure to engage on the agreement after repeated outreach, while Zambia has pushed back and said its concerns should be handled through diplomatic channels. The dispute has turned a technical funding package into a test of whether aid, sovereignty and U.S. leverage can coexist when negotiations break down.

The proposed five-year arrangement would cover HIV, tuberculosis, malaria, maternal and child health, polio and measles vaccination, and pandemic surveillance. Earlier reporting said Zambia would be expected to provide about $340 million in co-financing over the same period. Health GAP said the talks had been stalled for months and had been expected to end with a signature on Dec. 11, 2025.

The stakes are large because the U.S. already remains a major health backer in Zambia. The State Department says U.S. assistance to the country is close to $500 million a year, much of it directed to HIV/AIDS, health, education, governance, water and sanitation. Through PEPFAR, Washington says it has invested more than $100 billion globally in the HIV/AIDS response.

The draft memorandum, which circulated publicly in March 2026, framed the deal as a bilateral health cooperation framework while saying Zambia aimed to retain full sovereign authority over national public-health decisions. But health advocates warned that some revisions raised concerns about mining access and data-sharing, adding political friction to a deal that should have been about clinics and supply chains.

That sensitivity is heightened by Zambia’s economy, which depends heavily on copper. The State Department says copper generates more than 75% of export earnings and 44% of government revenue, making any perceived linkage between health aid and mining especially combustible in Lusaka. Zambia’s diplomatic relations with the United States date to 1964, but the present standoff shows how quickly a long-standing relationship can become contentious when the terms of assistance are seen as too intrusive.

The uncertainty also reaches beyond disease programs. The Zambia National Public Health Institute has used the 7-1-7 metric to assess outbreak response, including anthrax and cholera, and any disruption in planning could complicate surveillance and rapid response. Washington has said some aid will continue, including antiretroviral drugs and programs to prevent mother-to-child HIV transmission, but without a signed agreement the broader system remains exposed.